Form 4: Alzamend Neuro Director Milton C. Ault III Increases Stake in Company

Director Milton C. Ault III reports purchasing 25 shares of Alzamend Neuro, Inc. common stock at an average price of $3.7368 on July 31, 2024.

Summary

• On July 31, 2024, Milton C. Ault III, a director and 10% owner of Alzamend Neuro, Inc., purchased 25 shares of common stock at an average price of $3.7368.
• The purchase was made in open market transactions, with prices ranging from $3.592 to $3.95 per share.
• Following the transaction, Ault directly owns 16,686 shares and indirectly owns 77,193 shares through Ault Lending, LLC, 99,619 shares through Ault Life Sciences, Inc., and 549 shares through Ault Life Sciences Fund, LLC.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The purchase of shares by a director is generally viewed as a positive sign, but the quantity is small.

Positives

• The director's purchase of shares may signal confidence in the company's future prospects.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future performance. This purchase by a director could be interpreted as a positive signal.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Alzamend Neuro, ALZN, Milton C. Ault III, insider trading, beneficial ownership, Form 4, stock purchase